哪些临床和影像学特征可预测PI-RADS 3病灶中的临床显著性前列腺癌?一项高容量学术中心的回顾性研究
该回顾性研究纳入单中心2015年3月至2017年8月由3名高年资放射科医师之一评分的mpMRI PI-RADS 3病灶患者131例,csPCa检出31例(22.9%)。多因素分析显示较低前列腺体积(p=0.015)和较低肿瘤ADC与对侧前列腺ADC比值(ADCT/ADCCLP)(p<0.001)显著预测csPCa;外周带病灶联合前列腺体积<44 cc且ADCT/ADCCLP<70%的模型敏感度59%、特异度88%(AUC 0.780)。直肠指检可疑(p=0.011)和MRI报告提及前列腺炎(p=0.020)分别正向和负向影响临床医师对PI-RADS 3病灶进行活检的决策。
要点
- PI-RADS 3病灶中csPCa检出率为22.9%(31/131)。
- 较低前列腺体积(p=0.015)和较低ADCT/ADCCLP(p<0.001)独立预测csPCa。
- 外周带模型(体积<44 cc且ADCT/ADCCLP<70%)敏感度59%、特异度88%、AUC 0.780。
核心结论
- 前列腺体积和肿瘤ADC与对侧前列腺ADC比值有潜力预测PI-RADS 3病灶中的csPCa,敏感度59%、特异度88%;可疑直肠指检和MRI报告提及前列腺炎影响临床医师对PI-RADS 3病灶的活检决策。
研究设计与样本
- 单中心高容量学术中心回顾性研究,纳入2015年3月至2017年8月由3名高年资放射科医师之一评分的mpMRI PI-RADS 3病灶患者131例,评分基于T2加权和DWI序列,参考标准为活检病理检出csPCa。
关键影像表现/征象
- PI-RADS 3病灶基于T2加权和DWI序列评分。
- 在DWI序列上计算肿瘤感兴趣区ADC及对侧相应部位ADC。
诊断标准与关键数值
- 外周带病灶:仅对前列腺体积<44 cc且ADCT/ADCCLP<70%的PI-RADS 3病灶行活检,检出csPCa敏感度59%、特异度88%、AUC 0.780。
- 多因素分析:较低前列腺体积(p=0.015)和较低ADCT/ADCCLP(p<0.001)显著预测csPCa。
- 移行带病灶:既往阴性活检(p=0.044)预测csPCa。
临床应用与阅片要点
- MRI报告提及前列腺炎(p=0.020)负向影响临床医师对PI-RADS 3病灶的活检决策。
- 可疑直肠指检(p=0.011)正向影响临床医师对PI-RADS 3病灶的活检决策。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate which clinical and radiological characteristics can predict clinically significant prostate cancer (csPCa) in PI-RADS 3 lesions. To investigate which clinical and radiological characteristics influence the clinician to biopsy a PI-RADS 3 lesion.
MATERIALS AND METHODS: mpMRI PI-RADS 3 lesions scored by 1 out of 3 highly specialized radiologists in a single high-volume center during the period March 2015 to August 2017 were investigated. This score was based on T2 weighted and diffusion weighted imaging (DWI) sequences. Clinical characteristics of all patients with PI-RADS 3 lesions were collected from medical records. Radiological characteristics were collected from radiology reports. Some radiological characteristics such as apparent diffusion coefficient (ADC) in a region of interest at the tumor site and ADC at a site contralateral to the tumor site were calculated on DWI sequences. Cox regression analysis was performed to identify which characteristics could predict csPCa in PI-RADS 3 lesions and which characteristics could influence the behavior of a clinician whether or not to biopsy a PI-RADS 3 lesion.
RESULTS: csPCa could be detected in 31 out of 131 patients with PI-RADS 3 lesions (22.9%). A lower median prostate volume (p = 0.015) and a lower ratio of ADC of the tumor on ADC of the contralateral prostate (ADCT/ADCCLP) (p < 0.001) significantly predisposed for csPCa in multivariate logistic regression. For peripheral zone lesions, a diagnostic model with biopsy of only those PI-RADS 3 lesions with a prostate volume <44 cc and a ratio of ADCT/ADCCLP < 70% showed a sensitivity for detection of csPCa of 59% with a specificity of 88%. (area under the curve 0.780) A suspicious rectal examination (p = 0.011) and the mentioning of prostatitis on the MRI report (p = 0.020) influenced clinicians to biopsy a PI-RADS 3 lesion positively and negatively respectively. For transition zone lesions, previous negative biopsies (p = 0.044) predisposed for csPCa.
CONCLUSION: Prostate volume and the ratio of ADC tumor on ADC of the contralateral prostate have the potential to predict csPCa in PI-RADS 3 lesions with a sensitivity of 59% and specificity of 88%. A suspicious rectal examination and the mentioning of prostatitis on the MRI report influenced the decision of clinicians to biopsy a PI-RADS 3 lesion.
引用
- Hermie I, Van Besien J, De Visschere P, et al. Which clinical and radiological characteristics can predict clinically significant prostate cancer in PI-RADS 3 lesions? A retrospective study in a high-volume academic center. Eur J Radiol. 2019. PMID: 31005183. doi:10.1016/j.ejrad.2019.02.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。